These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 3332181

  • 21. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P, Miklos S, Olkiewicz KM, Müller G, Andreesen R, Holler E, Cooke KR, Hildebrandt GC.
    Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
    [Abstract] [Full Text] [Related]

  • 22. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
    Affaticati P, Locatelli F, Roggero S, Marmont F, Falda M, Dall'Omo AM, Busca A, Ceretto C, Praticò L, Berrino M, Curtoni ES.
    Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
    [Abstract] [Full Text] [Related]

  • 23. Towards an objective prognostic index of acute graft-versus-host disease.
    Sahmoud TM, Heudes D, Irinopoulou T, Gluckman E, Nguyen Q, Brocheriou C, Devergie A, Rigaut JP, Mary JY.
    Anal Cell Pathol; 1993 Sep; 5(5):289-97. PubMed ID: 8217909
    [Abstract] [Full Text] [Related]

  • 24. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
    Toubai T, Tanaka J, Nishihira J, Ohkawara T, Hirate D, Kondo N, Tone S, Shono Y, Ibata M, Sugita J, Kato N, Miura Y, Iwao N, Ota S, Imamura M.
    Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
    [Abstract] [Full Text] [Related]

  • 25. Graft-versus-host disease after marrow transplantation.
    Storb R.
    Prog Clin Biol Res; 1986 Aug; 224():139-57. PubMed ID: 3540990
    [Abstract] [Full Text] [Related]

  • 26. The graft-versus-leukaemia effect after allogeneic bone-marrow transplantation: assessment through competing risks approaches.
    Katsahian S, Porcher R, Mary JY, Chevret S.
    Stat Med; 2004 Dec 30; 23(24):3851-63. PubMed ID: 15580602
    [Abstract] [Full Text] [Related]

  • 27. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M, Matzku S.
    Arch Immunol Ther Exp (Warsz); 2002 Dec 30; 50(3):197-224. PubMed ID: 12098935
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
    Li S, Xu KL, Li ZY, Pan XY, Sun HY, Li DP, Cao J, Du B.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 30; 28(11):727-30. PubMed ID: 18457261
    [Abstract] [Full Text] [Related]

  • 31. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
    Xue F, Chen W, Wang X, Wang L, Xu G, Liang L, Bai X, Liang T.
    Transpl Immunol; 2009 Mar 30; 20(4):232-7. PubMed ID: 19041396
    [Abstract] [Full Text] [Related]

  • 32. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J, Mahé B, Milpied N, Devilder MC, Dréno B, Bignon JD, Davodeau F, Hallet MM, Bonneville M, Vié H.
    J Clin Invest; 1993 Jan 30; 91(1):12-20. PubMed ID: 8423212
    [Abstract] [Full Text] [Related]

  • 33. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A, Allebes WA, Voorter CE, van den Berg-Loonen EM, Schattenberg AV, de Witte TJ, Joosten I.
    Bone Marrow Transplant; 1998 Dec 30; 22(11):1049-55. PubMed ID: 9877266
    [Abstract] [Full Text] [Related]

  • 34. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP, Li Z, Nador RG, Strober S.
    Transplantation; 2008 Feb 27; 85(4):607-14. PubMed ID: 18347541
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.
    Guillén FJ, Ferrara J, Hancock WW, Messadi D, Fonferko E, Burakoff SJ, Murphy GF.
    Lab Invest; 1986 Jul 27; 55(1):35-42. PubMed ID: 3523039
    [Abstract] [Full Text] [Related]

  • 37. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M, Bagattini S, Chabannon C, Faucher C, Bardou VJ, Bilger K, Vey N, Gaugler B, Stoppa AM, Coso D, Ladaique P, Olive D, Viens P, Blaise D.
    Exp Hematol; 2004 Nov 27; 32(11):1097-102. PubMed ID: 15539088
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
    Uberti JP, Ayash L, Ratanatharathorn V, Silver S, Reynolds C, Becker M, Reddy P, Cooke KR, Yanik G, Whitfield J, Jones D, Hutchinson R, Braun T, Ferrara JL, Levine JE.
    Biol Blood Marrow Transplant; 2005 Sep 27; 11(9):680-7. PubMed ID: 16125638
    [Abstract] [Full Text] [Related]

  • 40. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S, Chen H, Wang H, Ma J, Pan S, Xue M, Zhu L, Liu J, Xiao M, Zhou L.
    Chin Med J (Engl); 2001 Feb 27; 114(2):191-5. PubMed ID: 11780205
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.